Il Yang to commercialize a new anti-leukemia drug soon.

Published: 2007-03-02 06:56:00

Updated: 2007-03-02 06:56:00

Il Yang has visualized its experimental new drug "IY5511" for the treatment of leukemia with recent animal in-vivo study reports, showing about 20 times more potent than Gleevec.

According to the study conducted by the Blood Internal Medicine Research Lab. of Catholic Medical School St. Mary...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK